ELISA Kit for C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9)
SER877HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9)
- Delivery Days Customer12
- Assay Detection Range15.6-1,000pg/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 5.7pg/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9). Standards or samples are ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Yang C, Xin JY, Liu ZL, et al. Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke. Neurol Ther. 2022,11(1):87-101. doi: 10.1007/s40120-021-00296-7Read this paper
- Yang J, Zhao D, Chen Y, et al. Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Investig. 2021,12(8):1442-1451. doi: 10.1111/jdi.13495Read this paper
- Moradi N, Fadaei R, Emamgholipour S, et al. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. PLoS One. 2018,13(1):e0192159. doi: 10.1371/journal.pone.0192159Read this paper
- Jia Y, Luo X, Ji Y, et al. Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance. Diabetes Res Clin Pract. 2017,131:116-123. doi: 10.1016/j.diabres.2017.07.003Read this paper
- Bai B, Ban B, Liu Z, et al. Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose. PLoS One. 2017,12(2):e0172271. doi: 10.1371/journal.pone.0172271Read this paper
- Asada M, Morioka T, Yamazaki Y, et al. Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction. J Diabetes Res. 2016,2016:8624313. doi: 10.1155/2016/8624313Read this paper
- Wolf RM, Steele KE, Peterson LA, et al. C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery. J Clin Endocrinol Metab. 2016,101(5):2211-7. doi: 10.1210/jc.2016-1027Read this paper
- Jung CH, Lee MJ, Kang YM, et al. Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2014,99(12):E2477-84. doi: 10.1210/jc.2014-2524Read this paper
- Hwang YC, Woo Oh S, Park SW, et al. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int J Obes (Lond). 2014,38(9):1207-12. doi: 10.1038/ijo.2013.242Read this paper
Related products
Product group Assays
- SizePrice
Product group Assays
Assay Sample TypeSerum, plasma and other biological fluids.
- SizePrice
Product group Assays
- SizePrice
Product group Assays
Assay Sample TypeSerum, plasma and other biological fluids
- SizePrice
Product group Assays
- SizePrice